Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells
Analysis of the binding mode to SCARB1 might guide further development and optimization of cystobactamids, along with related compound classes such as albicidin and coralmycin, for various possible therapeutic areas
Eli Lilly initiated the TRIUMPH Phase 3 program in late 2024 , with interim data expected to support a 2027 FDA submission and peak GLP-1 market sales projections of USD 12 to USD 18 billion
Taking acetyl-L-carnitine improves memory and mental function in older people with some memory loss
The IGF-I/IGFBP-3 axis: clinical applications in pediatric endocrinology
US$ 20.82
US$ 29.20
US$ 28.98
US$ 27.32
US$ 27.65
US$ 24.38
US$ 24.54
US$ 21.35
US$ 28.06
